162 related articles for article (PubMed ID: 19689515)
1. Experience with cyclosporine in children with chronic idiopathic urticaria.
Doshi DR; Weinberger MM
Pediatr Dermatol; 2009; 26(4):409-13. PubMed ID: 19689515
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic urticaria in children with antihistamines and cyclosporine.
Neverman L; Weinberger M
J Allergy Clin Immunol Pract; 2014; 2(4):434-8. PubMed ID: 25017532
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Monroe E; Finn A; Patel P; Guerrero R; Ratner P; Bernstein D;
J Am Acad Dermatol; 2003 Apr; 48(4):535-41. PubMed ID: 12664016
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
Wan KS
J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.
Baskan EB; Tunali S; Turker T; Saricaoglu H
J Dermatolog Treat; 2004 Jun; 15(3):164-8. PubMed ID: 15204149
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative.
Loria MP; Dambra PP; D'Oronzio L; Nettis E; Pannofino A; Cavallo E; Ferrannini A; Tursi A
Immunopharmacol Immunotoxicol; 2001 May; 23(2):205-13. PubMed ID: 11417848
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
[TBL] [Abstract][Full Text] [Related]
8. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation.
Serhat Inaloz H; Ozturk S; Akcali C; Kirtak N; Tarakcioglu M
J Dermatol; 2008 May; 35(5):276-82. PubMed ID: 18477227
[TBL] [Abstract][Full Text] [Related]
9. Factors that predict the success of cyclosporine treatment for chronic urticaria.
Hollander SM; Joo SS; Wedner HJ
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):523-8. PubMed ID: 22123382
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids.
Shahar E; Bergman R; Guttman-Yassky E; Pollack S
Int J Dermatol; 2006 Oct; 45(10):1224-7. PubMed ID: 17040448
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors in chronic urticaria.
Trojan TD; Khan DA
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):412-20. PubMed ID: 22729026
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation.
Di Gioacchino M; Di Stefano F; Cavallucci E; Verna N; Ramondo S; Paolini F; Caruso R; Schiavone C; Masci S; Santucci B; Paganelli R; Conti P
Allergy Asthma Proc; 2003; 24(4):285-90. PubMed ID: 12974197
[TBL] [Abstract][Full Text] [Related]
13. Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria.
Ohtsuka T
Int J Dermatol; 2010 May; 49(5):579-84. PubMed ID: 20534097
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Vena GA; Cassano N; Colombo D; Peruzzi E; Pigatto P;
J Am Acad Dermatol; 2006 Oct; 55(4):705-9. PubMed ID: 17010756
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
17. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.
Najib U; Bajwa ZH; Ostro MG; Sheikh J
Ann Allergy Asthma Immunol; 2009 Dec; 103(6):496-501. PubMed ID: 20084843
[TBL] [Abstract][Full Text] [Related]
18. What the first 10,000 patients with chronic urticaria have taught me: a personal journey.
Kaplan AP
J Allergy Clin Immunol; 2009 Mar; 123(3):713-7. PubMed ID: 19081615
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
20. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.
Metz M; Ohanyan T; Church MK; Maurer M
JAMA Dermatol; 2014 Mar; 150(3):288-90. PubMed ID: 24477320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
